THE ROLE OF NURSE STUFF IN EDUCATE OLDER PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SAUDI ARABIA
Main Article Content
Keywords
Health-related quality of life, Medication adherence, Type 2 diabetes mellitus, Over 50 patients.
Abstract
Objectives: This cross-sectional study examined 266 patients from the King Khaled Hospital in Najran, Saudi Arabia, in order to examine whether there is a relationship between the level of adherence to oral hypoglycemic medication (OHM) and health-related quality of life (HRQoL) in older patients diagnosed with Type 2 diabetes mellitus (T2DM).
Methods: The questionnaire that were used in this study combined the 8-item Morisky Medication Adherence Scale and the HRQoL with additional demographic questions. Pearson’s correlation matrix as well as ordinary least squares regression methodology were employed to test the relationship between the Morisky Medications Adherence scale and the HRQoL.
Key findings: Our analysis suggested that the overall score for HRQoL was comparable across all 4 sub-domains of: Physical (PQoL), Psychological (YQoL), Social Relationships (SRQoL) and Environment (EQoL). The mean average for medication adherence (MA) stood at approximately 5. Our findings supported the hypothesis that patients adhering to their medication exhibit higher levels of HRQoL. Furthermore, there was no statistical significance in relation to education as the sample was concentrated at the primary level, suggesting that participants left school at the approximate age of 11. When examining the sub-samples based on gender, there was no difference between males and females regarding the correlation between MA and HRQoL apart from in the PQoL which showed that females had a significantly higher correlation than males.
Conclusion: The reported positive correlation can give healthcare providers confidence and an expectation that there will be more initiatives that enhance MA. Improved MA must be initiated with advancements in medication safety and a reduction in prescription errors.
References
2. Aloudah, N.M. et al. Medication adherence among patients with Type 2 diabetes: A mixed methods study. PloS One 2018; 13(12), p.e0207583.
3. Al-Rubeaan, K et al. The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM). Annals of Saudi Medicine 2014; 34(6), pp.465-475.
4. Alzaheb, R.A., Altemani, A.H., The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018; 11, p.15.
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Supplement 1), pp.S62-S69.
6. Arulmozhi, S., Mahalakshmy, T. Self-care and medication adherence among type 2 diabetics in Puducherry, Southern India: A hospital based study. Journal of Clinical and Diagnostic Research 2014; JCDR, 8(4), p.UC01.
7. Asche, C. et al. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics 2011; 33(1), pp.74-109.
8. Atlas, I.D. 8th. International Diabetes Federation, 8th edn, 2017.
9. Badedi, M. et al. Factors associated with long-term control of type 2 diabetes mellitus. Journal of Diabetes Research 2015; PP.1-8.
10. Billups, S.J. et al. The relationship between drug therapy noncompliance and patient characteristics, health‐related quality of life, and health care costs. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2000; 20(8), pp.941-949.
11. Boccuzzi, S.J. et al. Utilization of oral hypoglycemic agents in a drug-insured US population. Diabetes Care 2001; 24(8), pp.1411-1415.
12. Campbell, R.K. et al. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. Journal of the American Pharmacists Association 2009; 49(5), pp.S3-S9.
13. Chew, B.H. Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study. Quality of Life Research 2015; 24(11), pp.2723-2731.
14. Chew, B.H. et al. Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study. Patient Preference and Adherence 2015; 9, p.639.
15. Cho, N.H. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice 2018; 138, pp.271-281.
16. Côté, I. et al. Is adherence to drug treatment correlated with health-related quality of life?. Quality of Life Research 2003; 12(6), pp.621-633.
17. Haynes, RB. et al. Compliance in health care. Baltimore: John Hopkins University Press, 1979.
18. Heissam, K., Abuamer, Z. et al. Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: A cross section study. The Pan African Medical Journal 2015; l, 20.
19. Holzemer, W.L. et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS patient care and STDs 1999; 13(3), pp.185-197.
20. King, H., Dowd, J.E. Primary prevention of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33(1), pp.3-8.
21. Killewo, J. et al. Epidemiology and demography in public health. Academic Press, 2010.
22. Jannoo, Z. et al. Examining diabetes distress, medication adherence, diabetes self-care activities, diabetes-specific quality of life and health-related quality of life among type 2 diabetes mellitus patients. Journal of Clinical and Translational Endocrinology 2017; 9, pp.48-54.
23. Lee, G.K. et al. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PloS One 2013; 8(4), p.e62775.
24. Manan, M.M. et al. Interplay between oral hypoglycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. Journal of Clinical and Diagnostic Research 2014; JCDR, 8(12), p.JC05.
25. Martínez, Y.V. et al. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Services Research 2008; 8(1), p.164.
26. Mitka, M. Report quantifies diabetes complications. Jama 2007; 297(21), pp.2337-2338.
27. Mohd, M.M. et al. The predictors to medication adherence among adults with diabetes in the United Arab Emirates. Journal of Diabetes & Metabolic Disorders 2015; 15(1), p.30.
28. Morisky, D.E. et al. Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension 2008; 10(5), pp.348-354.
29. Ohlson, L.O. et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988; 31(11), pp.798-805.
30. Ose, D. et al. Health related quality of life and comorbidity. A descriptive analysis comparing EQ-5D dimensions of patients in the German disease management program for type 2 diabetes and patients in routine care. BMC Health Services Research 2011; 11(1), p.179.
31. Osterberg, L., Blaschke, T. Adherence to medication. New England Journal of Medicine 2005; 353(5), pp.487-497.
32. Perwitasari, D.A., Urbayatun, S. Treatment adherence and quality of life in diabetes mellitus patients in Indonesia. Sage Open 2016; 6(2), p.2158244016643748.
33. Rejeski, W.J., Mihalko, S.L. Physical activity and quality of life in older adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001; 56(suppl_2), pp.23-35.
34. Saleh, F. et al. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health 2014; 14(1), p.431.
35. Sung, J.C. et al. Factors affecting patient compliance with anti hyperlipidemic medications in an HMO population. Am J Manag Care 1998; 4(10), pp.1421-1430.
36. Tuomilehto, J. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001; 344(18), pp.1343-1350.
37. Way, K.L. et al. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes and Metabolism Journal 2016; 40(4), pp.253-271.
38. World Health Organization. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment: field trial version December 1996; (No. WHOQOL-BREF). Geneva: World Health Organization.
39. World Health Organization. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation 2003; (Vol. 916). World Health Organization.
40. Zheng, Y. et al. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology 2018; 14(2), p.88.
41. Zhuo, X. et al. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. American Journal of Preventive Medicine 2013; 45(3), pp.253-261.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Nourah Reja A Al-Mutairi
Nurse, Al-Faha Phc Al-Majmah
Eman Hamdan Hamoud Almutairi
Nurse, Al-FAHA PHC AL-MAJMAH
Norah Awad Alanazi
Nurse, AL-FAHA PHC AL-MAJMAH
Reham Abdallah Alsadi
Nure, AL-FAHA PHC AL-MAJMAH
Maha Suhail Al-Mutairi
Nurse, AL- FAHA PHC AL-MAJMAH
Nawal Awad Alanazi
Nurse, Al rawdhah 1 health center Riyadh
Aliaa Awad Alanazi
Nurse, Al rawdhah 1 health center Riyadh
Hanan Hassan Alanezi
Nurse, South Naseem Health Center Riyadh
Sahar Nasser Alshahrani
Nurse, laban alsharqi phc Riyadh
